Location: Tel Aviv, Israel
CIK: 0001599719 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 15, 2017
Total Value: $1.245B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VNQ | VANGUARD INDEX FDS | 8,513,724 | $703M | 56.5% | $74.30 | — | REIT ETF | 922908553 |
| SPY | SPDR S&P 500 ETF TR | 646,410 | $144M | 11.6% | $202.35 | — | TR UNIT | 78462F103 |
| IWM | ISHARES RUSSEL 2000 ETF | 716,300 | $96.59M | 7.8% | $134.85 | — | WTH | 464287655 |
| XLF | FINANCIAL SELECT SECTOR SPDR | 4,135,250 | $96.14M | 7.7% | $23.25 | — | TR UNIT | 81369Y605 |
| XLY | CONSUMER DISCRETIONARY SELT | 999,120 | $81.33M | 6.5% | $80.04 | — | SELT | 81369Y407 |
| ORA | ORMAT TECHNOLOGIES INC | 728,326 | $39.05M | 3.1% | $24.60 | +85.6% | COM | 686688102 |
| OPK | OPKO HEALTH INC | 3,116,605 | $28.98M | 2.3% | $11.70 | -11.6% | COM | 68375N103 |
| EEM | ISHARES TR | 550,005 | $19.25M | 1.5% | $38.78 | — | MSCI EMG MKT ETF | 464287234 |
| EWJ | ISHARES | 377,362 | $18.44M | 1.5% | $36.08 | — | MSCI JAPAN ETF | 46434G822 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 226,789 | $8.221M | 0.7% | $57.15 | — | ADR | 881624209 |
| VWO | VANGUARD INTL EQUITY INDEX F | 115,534 | $4.134M | 0.3% | $38.17 | — | FTSE EMR MKT ETF | 922042858 |
| VPL | VANGUARD INTL EQUITY INDEX F | 47,443 | $2.757M | 0.2% | $60.62 | — | FTSE PACIFIC ETF | 922042866 |
| XLU | SELECT SECTOR SPDR TR | 15,500 | $753K | 0.1% | $52.45 | — | SBI INT-UTILS | 81369Y886 |
| VOO | VANGUARD INDEX FDS | 2,500 | $513K | 0.0% | $186.91 | — | S&P 500 ETF SHS | 922908363 |
| EPP | ISHARES | 11,795 | $466K | 0.0% | $40.98 | — | MSCI PAC JP ETF | 464286665 |
| IVV | ISHARES TR | 1,985 | $447K | 0.0% | $185.62 | — | CORE S&P500 ETF | 464287200 |
| — | POWERSHARES QQQ TRUST | 3,755 | $445K | 0.0% | $91.95 | — | UNIT SER 1 | 73935A104 |
| — | ONCOCYTE CORPORATION | 571 | $4,000 | 0.0% | $5.25 | — | COM | 68235C107 |